of New Subsidiary (Revised No.2) on 3 April 2017    The Board of Directors Meeting of Ekachai Medical Care Public Company Limited (the “Company”) No. 1/2018  held on 26th February 2018 has passed a

 / CS / 2560/016 Establishment of New Subsidiary (Revised No.2) on 3 April 2017    The Board of Directors Meeting of Ekachai Medical Care Public Company Limited (the “Company”) No. 1/2018  held on 26th

the past 6 months prior to the approvals of the Board of Directors as mentioned above, i.e. the approval of the Board of Directors of the Company for the additional investment in Landy Development Co

specified in the Notification of the Securities and Exchange Commission with the approval of the Cabinet, excluding any currencies; “derivatives exchange” means an entity licensed to operate business as a

the approval of the Board of Directors meeting. 2 Related Parties Lessee : UBIS (Asia) Public Company Limited Lessor : Golden Arrow Coating Co., Ltd.* Relationship : Golden Arrow Coating Co., Ltd.* - Mr

Baht on 3rd June 2020 3) To pay for 20 Million Baht on 3rd June 2021 The company will sign the contract for all the 3 plots and will pay the deposit 20 Million Baht later after getting the approval from

February 22, 2018 Notification on the Asset Acquisition of Wattanapat Hospital Trang Public Company Limited (“the Company”) According to the Company‘s Board of Directors’ Meeting No.1/2018,held on 21

Thailand (SET)’s Electronic Listed Company Information Transmission System (SETLink). Regarding the PP share offering at a specified price, the SEC considers approval granted if the shareholders’ meeting

trading orders from the client. {A} admitted that she accepted trading orders via her mobile. The SEC found that {A} intended to avoid complying with conducts of securities company in relation to record

. Report/Form (Notification of Securities and Exchange Commission) (Synopsis)   12/11/2007 01/01/2007 4. Report/Form (Notification of Securities and Exchange Commission) Form 90/91-1 Approval for Persons who